Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (5243)	9/1/1998 6:09:00 PM
From: Captain Jack	Read Replies (1) \| Respond to of 6136

Steve --- the range you state would shock me. All of the mkt is a gamble and biotechs can be a real trip with a ton of volatility. AGPH is followed buy at least a dozen analysts and none -- read zero -- of them have a sell rec.Actually the three worst are hold and the others are buy or strong buy. I would like to see something come out of the pipeline as approved now instead of later. As long as no one comes out with a better AIDS drug with little side effects agph should be fine. As a trader I still held which is unheard of as an issue drops like this one did on me. A little meaty PR would not hurt either but they do have a rep as honest and reserved which helps in good and bad mkts. I still have a target of 38 - 40 in the next 6 - 9 months if nothing new comes out to shorten the time frame or the world does not have some other crap go wrong. Here is where I added to my OIL sector holdings that also went to hell recently,,, they are in the same catagory... sure was not going to avg this one down as I feel it will be fine on its own.. (I do not chase them down anyway!). John